Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Cognitive Function in Older People With MCI
NCT02180529Terminated
- Sponsor
- Meir Medical Center
- Start
- Nov 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Mild Cognitive Impairment (MCI) comparing Methylphenidate with Placebo (2 arms). Primary endpoint: Cognitive Function (Mindstreams and MoCA) at Day 4. Started Nov 2015; status: terminated.
02
Drugs
methylphenidate
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT02180529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180529.